BioIntellisense Stock
HealthTechLooking to sell BioIntellisense stock or options?
Contact usBioIntellisense has developed a clinical intelligence platform designed to provide continuous health monitoring, predictive analytics and algorithmic insights. The company's platform leverages a sensor-enabled device that is worn on the skin, offering medical-grade monitoring services. The device performs advanced analytics and data services for early detection of skin temperature, heart rate, respiratory rate, fall detection, coughing, sneezing and vomiting frequency, providing real-time data to the platform. This enables hospitals to assess vital signs, physiological biometrics and symptomatic events of patients.
Chimera Capital, Dexcom Ventures, Mary Tolan, University of Colorado Health, Pendrell, Philips, iD Ventures America, TT Capital Partners, Fresenius Medical Care, Royal Philips Electronics (Restoratives and Impression Portfolios), CU Healthcare Innovation Fund, Philips Ventures, Skypoint Ventures, United States Army, James Murren, TLG Capital Management, Jonathan Weiner.
Looking to sell BioIntellisense Stock or Options?
We have an even better solution: The Collective Exchange Fund
Get in touch and see if we can help you